Skip to the content
Investors
Careers
Seek Labslogo darklogo light
  • About Us
  • Innovations
    • BioSeeker™ Discovery Engine
    • PTAP™ Therapeutics
    • SeekIt™ Diagnostics
  • Seekers
  • Partnering
  • News
  • Contact Us
Seek Labs
  • About Us
  • Innovations
    • BioSeeker™ Discovery Engine
    • PTAP™ Therapeutics
    • SeekIt™ Diagnostics
  • Seekers
  • Partnering
  • News
  • Contact Us
Seek Labs
  • About Us
  • Innovations
    • Therapeutics
    • Diagnostics
      • Point of Care Use Cases
      • Key Innovations
      • Communication
      • SeekIt™
  • Seekers
  • Partnering
  • News
  • Contact Us
  • Investors
  • Careers
Featured Therapeutics

Seek Labs Announces Inclusion of Veterinary Diseases in Global Disease Atlas

Seek Labs Announces Inclusion of Veterinary Diseases in Global Disease Atlas, Accelerating Development of Therapeutics to Bolster Global Protein Supply Chains July 22, 2025 SALT LA

Bridget Baldwin
July 22, 2025
0 Comments
Corporate Featured Therapeutics

BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)

BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV) July 8, 2025 Read the Medium Article from our CEO, Jared Bauer

Bridget Baldwin
July 8, 2025
0 Comments
350 W 800 N, Suite 220
Salt Lake City, UT 84103
  • About Us
  • Seekers
  • Contact Us
  • Investors
  • 2024 Responsibility Report
  • Innovations
  • Therapeutics
  • Diagnostics

    By submitting this form, you agree to our Terms of Service and Privacy Policy.

    Multiple Patents Pending | Copyright 2023 All Rights Reserved

    Terms of Service | Privacy Policy

    BioSeeker, PTAP, and SeekIt are investigational platforms currently in preclinical development. Not cleared or approved by the FDA or any other regulatory agency..

    Back to top Drag